Benedetto,A.V. Environment and skinaging. Clin.Derm. 16,129^139 (1998).
Stegman, S.J., Tromovitch, T.A. and Glogau, R.G.The skin of the aging face in cosmetic dermatologic surgery, 2nd edn. Mosby year book, St. Louis. MO, pp. 5^15 (1990).
Benedetto, A.V. The cosmetic use of Botulinum neurotoxintype A. Int. J. Derm.38,641^655 (1999).
Frankel, A.S. Botox for rejuvenation of the periorbital region. Facial Plast. Surg.15,255^262 (1999).
Gutierrez, L.M., Canaves, J., Ferrer-Montiel, A., Reig,J.A., Montal, M. and Viniegra, S. A peptide that mimics the carboxy-terminal domain of SNAP-25 blocks Ca2þdependent exocytosis in chroma⁄n cells. FEBS Lett. 372,39^43 (1995).
Gutierrez, L.M., Viniegra, S., Rueda, J., Ferrer-Montiel, A.V., Canaves, J.M. andMontal,M. Apeptide thatmimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chroma⁄n cells. J. Biol. Chem. 272, 2634^2639 (1997).
Ferrer-Montiel, A.V., Gutierrez, L.M., Apland, J.P., et al. The 26-mer peptide released from SNAP-25 by botulinum neurotoxin E inhibits vesicle docking. FEBS Lett. 435,84^88 (1998)
Blanes-Mira, J. Clementey, G. Jodasy, A. Ferna¤ndez-Ballester, B. Ponsatiy, L. Gutierrezz, E. Perez-Payaand A. Ferrer-Montiel. A synthetic hexapeptide (Argireline) with antiwrinkle activity. International Journal of Cosmetic Science, 2002, 24, 303^310.
MARYP. LUPO, ANNAL. COLE. Cosmeceutical peptides. Dermatologic Therapy, Vol. 20, 2007, 343–349. Printed in the United States · All rights reserved.